Pharmaceutical News Headlines for July 20 2012 ( Friday )


• Onyx Pharmaceuticals, Inc. (ONXX) Soars as FDA OKs Multiple Myeloma Drug More...

• Roche (RHHBY) Moves Secret Heart Drug to Phase III Trial More...

• Bristol-Myers Squibb Company (BMY) Drug Fails Liver Cancer Trial More...

• EnVivo Pharmaceuticals, Inc.' Drug Helps Memory in Early Study More...

• Sanofi (France) (SAN.PA) and Regeneron Pharmaceuticals, Inc. (REGN) Launch Comprehensive Phase 3 Clinical Program With LDL Cholesterol-Lowering PCSK9 Antibody More...

• Bionor Pharma ASA's Therapeutic HIV Vaccine Vacc-4x Improves Quality of Immune Responses in HIV Patients, Resulting in Long-Term Reduction in Viral Load and Potential for Periodic "Boosts" That Could Result in New Treatment Option for People Living With HIV/AIDS More...

• Johnson & Johnson (JNJ) Recalls Some Duragesic Pain Patches More...

• Merck & Co., Inc. (MRK) May Have Solved Sleeping Pill Problem that GlaxoSmithKline (GSK), Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Failed at More...

• Astex Pharmaceuticals (ASTX) Release: DACOGEN® Receives a Positive Regulatory Recommendation in the European Union for Treatment of Acute Myeloid Leukemia More...

• Millennium: The Takeda Oncology Company and Takeda Pharmaceutical Co. Ltd. (TKDG.DE) Announce Positive CHMP Opinion for Conditional Approval of ADCETRIS├é® (brentuximab vedotin) in Europe More...

• Seattle Genetics, Inc. (SGEN) Announces ADCETRIS® Receives Positive CHMP Opinion for Conditional Approval in European Union More...

• First Gene Therapy in Western World From uniQure Receives Positive Opinion in Europe from CHMP More...

• Alcohol in Moderation Cuts Kidney Cancer Risk, Boston University Medical Center Study More...

• Older U.S. Women More Likely to Drink While Pregnant, Centers for Disease Control and Prevention (CDC) Study More...

• Infection With 2 HIV Strains Slows Disease Progression, Lund University Study More...

• Opiates' Side Effects Rooted in Patients' Genetics, Stanford University School of Medicine Study Shows More...

• Vitamins Helped Beat Quake Stress: University of Canterbury Study More...

• VIVUS, Inc. (VVUS) Diet Pill Patents are Questioned and Stock Sinks More...

• FDA Whistleblower Has Stirred the Pot Before More...

• Pfizer Inc. (PFE) Trips Up Generic Drugmakers' Plan for Lyrica More...

• Johnson & Johnson (JNJ) Will Pay $2.2 Billion in Risperdal Settlement More...

• Merck KGaA (MKGAF.PK) Talks With Swiss Employees Go Nowhere More...

• Nuvo Research Inc. (NRI.TO) to Receive US $6.0 Million of Milestone Payments From Pliaglis® E.U. Approvals More...

• Sunshine Biopharma, Inc. Engages Beta Pharma Canada for Manufacturing of an Initial Batch of Adva-27a More...

• The PROOF Centre of Excellence Partners with OriGene Technologieson Heart & Kidney Transplant Biomarker Program More...

• Patient Advocate Foundation and Jazz Pharmaceuticals, Inc. (JAZZ) Announce Partnership for Narcolepsy CareLine More...

• BioDiem Ltd. (BDM.AX) Signs Agreement With Royal Melbourne Institute of Technology (RMIT) to Create New Non-influenza Vaccines More...

• Supernus Pharmaceuticals (SUPN) Appoints Dr. Stefan Schwabe, MD, PhD as Exec. VP R&D and Chief Medical Officer More...

• Dr. Reddy's Laboratories Ltd. (RDY)'s Net Up 28% on Generics Push More...

• Aegerion Pharmaceuticals, Inc. to Announce Second Quarter 2012 Financial Results on Wednesday, August 8 More...

• Alkermes plc (ALKS) to Host Conference Call to Discuss Financial Results for First Quarter of Fiscal 2013 More...

• Anika Therapeutics (ANIK) Announces Date of Second-Quarter 2012 Financial Results Conference Call More...

• Cubist Pharmaceuticals, Inc. (CBST) Increases Revenue 30% to $231 Million in the Second Quarter More...

• DNA Genotek is Awarded Key Patent for Oral Sample System More...
Tags: , ,

About author

Make it happen !!

0 comments

Leave a Reply